The trial is designed for cognitively healthy adults, aged 60 to 75 years old, who carry at least one copy of the APOE4 gene and have a build-up of cerebral amyloid in the brain, both risk markers for Alzheimer’s.
My name is Drew Linsley, and I am a Postdoctoral Research Fellow associated with the Brown Institute for Brain Science (BIBS) and the Initiative for Computation in Brain and Mind (CBM).
I am a postdoctoral researcher working on computational models of human learning and decision processes, with a special focus on how people search for and select from available information to build accurate representations of the world.
My academic interests in high school were primarily rooted in the biological sciences. However, I also very much enjoyed studying mathematics, history, English literature, and religion.
The brain is superbly important but remains pretty mysterious. I think it's important to understand how certain mutations or certain ailments can affect the brain and its functions in order to begin proper treatment.
I really enjoy spending time outdoors running, camping, and hiking. Or just spending a day on the green enjoying the sun. Anything to get the most out of a good day.
I worked on a project titled "Impact of Physiologic Factors on the Progression of Acute Traumatic Subdural Hemorrhage" in the lab of Dr. Wael F. Asaad.
The Brown Institute for Brain Science has awarded six graduate research awards for the 2017/2018 Academic Year. These awards recognize early career scientists who have made outstanding achievements as graduate students and have demonstrated strong potential for successful lifelong scientific careers.
I got interested in brain science after reading Oliver Sack's "The Man Who Mistook His Wife for a Hat." It got me to start wondering about the mechanisms behind perception and cognition.
I came to Brown because I wanted to study neuroscience, and even back in the 1980's Brown had one of biggest and best neuroscience programs in the country, where undergraduates could perform research.
I am Professor of Biology and Neuroscience at Carnegie Mellon University. Research in my lab is focused on understanding how experience assembles and alters the properties of neural circuits in the cerebral cortex, in both normal and disease states.
I am a Professor of Neuroscience at the Mortimer Zuckerman Mind Brain Behavior Institute, the Kavli Institute and the Department of Neuroscience, Columbia University, and I am an Investigator of the Howard Hughes Medical Institute.
I lead Research and Development for an emerging biotech company that is focused on creating novel medicines for people with a variety of brain disorders, such as Autism, Schizophrenia and Depression.
I am the Executive Director for the Neuroscience Institute at NYU Langone Health, which means I oversee all the behind-the-scenes work (strategic, administrative, financial, programmatic, etc.) that supports the research and education goals of our institute and its faculty, trainees, and staff.